About Ceres Pharma
Ceres Pharma is a company based in Merelbeke (Belgium) founded in 2017 by Marc Coucke and Mario Debel was acquired by Naxicap in June 2021. The company has 31 employees as of December 31, 2022. Ceres Pharma has completed 4 acquisitions, including AMNOL, Aesculapius and Ceumed. Ceres Pharma offers products and services including Prescription Drugs and Food Supplements.
- Headquarter Merelbeke, Belgium
- Employees 31 as on 31 Dec, 2022
- Founders Marc Coucke, Mario Debel
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Ceres Pharma
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
$197.79 K (USD), Grant
Dec 01, 2023
-
Investors
European Union
& 1 more
-
Employee Count
31
as on Dec 31, 2022
-
Investments & Acquisitions
AMNOL
& 3 more
-
Acquired by
Naxicap
(Jun 01, 2021)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Ceres Pharma
Ceres Pharma offers a comprehensive portfolio of products and services, including Prescription Drugs and Food Supplements.
Development, production, and distribution of prescription drugs for women’s and family health are undertaken by Ceres Pharma
Production and distribution of food supplements and cosmetics for women’s and family health are carried out by Ceres Pharma
People of Ceres Pharma
Unlock access to complete
Funding Insights of Ceres Pharma
Investors in Ceres Pharma
Ceres Pharma has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include European Union and Naxicap.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Investments in small and medium-sized businesses are managed by Naxicap.
|
Locked | Locked | Locked | |
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked |
Investor details for Ceres Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Ceres Pharma
Ceres Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include AMNOL, Aesculapius and Ceumed.
Investment portfolio details for Ceres Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Plant-based healthcare supplements are offered via an online platform.
|
Locked | Locked | 2002 | Locked | |
|
Dermo-cosmetics products are manufactured by AMNOL in Italy.
|
Locked | Locked | 1978 | Locked | |
|
Pharmaceutical products, food supplements, and cosmetics are developed and sold.
|
Locked | Locked | 1959 | Locked |
Complete acquisition details for Ceres Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - Ceres Pharma
Detailed financials for Ceres Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Ceres Pharma Comparisons
Peer comparison for Ceres Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Ceres Pharma
Detailed competitors of Ceres Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Ceres Pharma
Complete news archive for Ceres Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ceres Pharma
Ceres Pharma was founded in 2017 and raised its 1st funding round 6 years after it was founded.
Ceres Pharma is headquartered in Merelbeke, Belgium. It is registered at Merelbeke, East Flanders, Belgium.
Mario Debel is the current CEO of Ceres Pharma. They have also founded this company.
As of Dec 31, 2022, the latest employee count at Ceres Pharma is 31.
Ceres Pharma was established in 2017 in Merelbeke, Belgium, within the health and wellness sector. A variety of nutritional supplements is produced and distributed, covering categories like calcium support, joint care, fatigue management, sports nutrition, dietary aids, intestinal health, anti-stress formulas, and skin treatments. Distribution occurs through collaborations with retail outlets. The firm was co-founded by Marc Coucke and Mario Debel, who holds the CEO position.
Ceres Pharma offers Prescription Drugs and Food Supplements.
Ceres Pharma has made 4 acquisitions, including AMNOL, Aesculapius, and Ceumed.
Ceres Pharma has 2 investors. Key investors include European Union, and Naxicap.